Drug Trial Radar · NCT02918019
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
Last checked: Nov 19, 2026Latest source record: Dec 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
517
Actual
Start
Sep 20, 2016
Primary completion
Apr 5, 2019
Study completion Jul 26, 2019
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Sep 28, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase IIb, randomized, placebo-controlled, double-blind, multicenter, multi-arm study which will evaluate efficacy, safety, and pharmacokinetic of MSTT1041A compared with placebo as add-on therapy in participants with severe, uncontrolled asthma who are receiving medium- or high-dose inhaled corticosteroid (ICS) therapy and at least one of the following additional controller medications: long-acting beta-agonists (LABA), leukotriene modifier (LTM), long-acting muscarinic antagonist (LAMA), or long-acting theophylline preparation. The total duration of this study for each participant is approximately 70 weeks including screening, run-in, treatment, and follow-up.
Conditions
- Asthma
Interventions
MSTT1041ADrug
MSTT1041A will be administered as subcutaneous injections.
PlaceboDrug
Placebo matched with MSTT1041A.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduction in Rate of Asthma ExacerbationsTime frame: Baseline to Week 54
Locations
138 sites in 15 countries. Site status is shown where the registry gives one.
Alabama Allergy & Asthma
Birmingham, Alabama
Del Sol Research Management
Tucson, Arizona
Kern Allergy Med Clinic, Inc.
Bakersfield, California
Allergy & Asthma Care Center of Southern California
Long Beach, California
CA Allergy & Asthma Med Grp; Medical Group, Inc.
Los Angeles, California
Jonathan Corren MD, Inc.
Los Angeles, California
Office of Robert N Wolfe MD
Los Angeles, California
Advances in Medicine
Rancho Mirage, California
Allergy & Asthma Consultants
Redwood City, California
Bensch Research Associates
Stockton, California
Allergy and Asthma Clinical Research, Inc.
Walnut Creek, California
IMMUNOe Research Centers
Centennial, Colorado
Asthma & Allergy; Associates, P.C.
Colorado Springs, Colorado
Western States Clinical Research, Inc
Wheat Ridge, Colorado
Yale University School Of Medicine
New Haven, Connecticut
Emerald Coast Research Associates
Panama City, Florida
Florida Premier Research Institute
Winter Park, Florida
Atlanta Allergy & Asth Clin PC
Stockbridge, Georgia
Asthma & Allergy of Idaho
Twin Falls, Idaho
Asthma, Allergy & Sinus Center
Baltimore, Maryland
Chesapeake Clinical Research Inc - CRN
Baltimore, Maryland
Genesis Clinical Research & Consulting, LLC
Fall River, Massachusetts
Infinity Medical Research Inc
North Dartmouth, Massachusetts
Midwest Clinical Research LLC
St Louis, Missouri
The Allergy and Asthma Center
Bellevue, Nebraska
Montefiore Medical Center
The Bronx, New York
American Health Research Inc.
Charlotte, North Carolina
Allergy & Respiratory Center
Canton, Ohio
Integrity People Services Research Company
Oklahoma City, Oklahoma
Vital Prospects Clin Res Pc
Tulsa, Oklahoma
Temple University Hospital
Philadelphia, Pennsylvania
Asthma & Allergy Physicians of Rhode Island Clinical Research Institute (AAPRI CRI)
Warwick, Rhode Island
Spartanburg Medical Research
Spartanburg, South Carolina
Clinical Research Solutions PC
Knoxville, Tennessee
Meharry Medical College; Clinical Trials Office
Nashville, Tennessee
TTS Research
Boerne, Texas
Elliot J. Ginchansky, MD, PA
Dallas, Texas
Pioneer Research Solutions
Houston, Texas
Metroplex Pulmonology & Sleep Center
McKinney, Texas
Allergy & Asthma Research Center
San Antonio, Texas
Showing 40 of 138 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.